These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 32116250

  • 1. Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial.
    Tomaszewski N, He X, Solomon V, Lee M, Mack WJ, Quinn JF, Braskie MN, Yassine HN.
    J Alzheimers Dis; 2020; 74(3):975-990. PubMed ID: 32116250
    [Abstract] [Full Text] [Related]

  • 2. The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease.
    Yassine HN, Rawat V, Mack WJ, Quinn JF, Yurko-Mauro K, Bailey-Hall E, Aisen PS, Chui HC, Schneider LS.
    Alzheimers Res Ther; 2016 Jun 30; 8():25. PubMed ID: 27358067
    [Abstract] [Full Text] [Related]

  • 3. Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial.
    Arellanes IC, Choe N, Solomon V, He X, Kavin B, Martinez AE, Kono N, Buennagel DP, Hazra N, Kim G, D'Orazio LM, McCleary C, Sagare A, Zlokovic BV, Hodis HN, Mack WJ, Chui HC, Harrington MG, Braskie MN, Schneider LS, Yassine HN.
    EBioMedicine; 2020 Sep 30; 59():102883. PubMed ID: 32690472
    [Abstract] [Full Text] [Related]

  • 4. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
    Freund Levi Y, Vedin I, Cederholm T, Basun H, Faxén Irving G, Eriksdotter M, Hjorth E, Schultzberg M, Vessby B, Wahlund LO, Salem N, Palmblad J.
    J Intern Med; 2014 Apr 30; 275(4):428-36. PubMed ID: 24410954
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Investigating the plasma-liver-brain axis of omega-3 fatty acid metabolism in mouse knock-in for the human apolipoprotein E epsilon 4 allele.
    Husain MA, Vachon A, Chouinard-Watkins R, Vandal M, Calon F, Plourde M.
    J Nutr Biochem; 2023 Jan 30; 111():109181. PubMed ID: 36220526
    [Abstract] [Full Text] [Related]

  • 7. The Pattern of Fatty Acids Displaced by EPA and DHA Following 12 Months Supplementation Varies between Blood Cell and Plasma Fractions.
    Walker CG, West AL, Browning LM, Madden J, Gambell JM, Jebb SA, Calder PC.
    Nutrients; 2015 Aug 03; 7(8):6281-93. PubMed ID: 26247960
    [Abstract] [Full Text] [Related]

  • 8. Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids.
    Lotrich FE, Sears B, McNamara RK.
    J Psychosom Res; 2013 Nov 03; 75(5):475-83. PubMed ID: 24182638
    [Abstract] [Full Text] [Related]

  • 9. Omega-3 Fatty Acid Plasma Levels Before and After Supplementation: Correlations with Mood and Clinical Outcomes in the Omega-3 and Therapy Studies.
    Arnold LE, Young AS, Belury MA, Cole RM, Gracious B, Seidenfeld AM, Wolfson H, Fristad MA.
    J Child Adolesc Psychopharmacol; 2017 Apr 03; 27(3):223-233. PubMed ID: 28157380
    [Abstract] [Full Text] [Related]

  • 10. Relationship between diet and plasma long-chain n-3 PUFAs in older people: impact of apolipoprotein E genotype.
    Samieri C, Lorrain S, Buaud B, Vaysse C, Berr C, Peuchant E, Cunnane SC, Barberger-Gateau P.
    J Lipid Res; 2013 Sep 03; 54(9):2559-67. PubMed ID: 23801662
    [Abstract] [Full Text] [Related]

  • 11. A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.
    Khan W, Giampietro V, Banaschewski T, Barker GJ, Bokde AL, Büchel C, Conrod P, Flor H, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Lemaître H, Nees F, Paus T, Pausova Z, Rietschel M, Smolka MN, Ströhle A, Gallinat J, Vellas B, Soininen H, Kloszewska I, Tsolaki M, Mecocci P, Spenger C, Villemagne VL, Masters CL, Muehlboeck JS, Bäckman L, Fratiglioni L, Kalpouzos G, Wahlund LO, Schumann G, Lovestone S, Williams SC, Westman E, Simmons A, Alzheimer–s Disease Neuroimaging Initiative, AddNeuroMed Consortium, Australian, Imaging, Biomarkers, and Lifestyle Study Research Group, IMAGEN consortium.
    J Alzheimers Dis; 2017 Sep 03; 56(3):1159-1174. PubMed ID: 28157104
    [Abstract] [Full Text] [Related]

  • 12. Baseline Findings of PreventE4: A Double-Blind Placebo Controlled Clinical Trial Testing High Dose DHA in APOE4 Carriers before the Onset of Dementia.
    Yassine HN, Arellanes IC, Mazmanian A, De La Cruz L, Martinez J, Contreras L, Kono N, Liu BS, Badie D, Bantugan MA, Grindon A, Urich T, D'Orazio L, Emmanuel BA, Chui HC, Mack WJ, Harrington MG, Braskie MN, Schneider LS.
    J Prev Alzheimers Dis; 2023 Sep 03; 10(4):810-820. PubMed ID: 37874103
    [Abstract] [Full Text] [Related]

  • 13. Relationships of Fatty Acids, Delta-5 Desaturase Activity, and Lipid Profiles in Men with Acute Coronary Syndrome.
    Arai K, Koba S, Yokota Y, Tsunoda F, Tsujita H, Kondo S, Tsukamoto S, Shoji M, Shinke T.
    J Atheroscler Thromb; 2020 Nov 01; 27(11):1216-1229. PubMed ID: 32595194
    [Abstract] [Full Text] [Related]

  • 14. A Diet Rich in Docosahexaenoic Acid Restores Liver Arachidonic Acid and Docosahexaenoic Acid Concentrations in Mice Homozygous for the Human Apolipoprotein E ε4 Allele.
    Chouinard-Watkins R, Pinçon A, Coulombe JD, Spencer R, Massenavette L, Plourde M.
    J Nutr; 2016 Jul 01; 146(7):1315-21. PubMed ID: 27306896
    [Abstract] [Full Text] [Related]

  • 15. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC.
    Am J Clin Nutr; 2001 Mar 01; 73(3):539-48. PubMed ID: 11237929
    [Abstract] [Full Text] [Related]

  • 16. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.
    Carney RM, Steinmeyer BC, Freedland KE, Rubin EH, Rich MW, Harris WS.
    J Clin Psychiatry; 2016 Feb 01; 77(2):e138-43. PubMed ID: 26930527
    [Abstract] [Full Text] [Related]

  • 17. The impact of an omega-3 fatty acid rich lipid emulsion on fatty acid profiles in critically ill septic patients.
    Hall TC, Bilku DK, Neal CP, Cooke J, Fisk HL, Calder PC, Dennison AR.
    Prostaglandins Leukot Essent Fatty Acids; 2016 Sep 01; 112():1-11. PubMed ID: 27637335
    [Abstract] [Full Text] [Related]

  • 18. Which has the stronger impact on coronary artery disease, eicosapentaenoic acid or docosahexaenoic acid?
    Iwamatsu K, Abe S, Nishida H, Kageyama M, Nasuno T, Sakuma M, Toyoda S, Inoue T.
    Hypertens Res; 2016 Apr 01; 39(4):272-5. PubMed ID: 26739870
    [Abstract] [Full Text] [Related]

  • 19. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS, Conquer JA, Thomas R.
    Reprod Nutr Dev; 2005 Apr 01; 45(5):549-58. PubMed ID: 16188207
    [Abstract] [Full Text] [Related]

  • 20. Correlation of omega-3 levels in serum phospholipid from 2053 human blood samples with key fatty acid ratios.
    Holub BJ, Wlodek M, Rowe W, Piekarski J.
    Nutr J; 2009 Dec 24; 8():58. PubMed ID: 20034401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.